Lv1
36 积分 2025-09-01 加入
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
7天前
已完结
Successful newborn screening for Gaucher disease using fluorometric assay in China
7天前
已完结
Carrier frequency and incidence of aromatic L-amino acid decarboxylase deficiency: a gnomAD-based study
7天前
已完结
FDA approves hereditary blindness gene therapy
7天前
已完结
Small cell lung cancer
17天前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
21天前
已关闭
Trends in the development of cellular and gene therapy in China
2个月前
已完结
Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity
2个月前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
The landscape for radioligand therapies in oncology
2个月前
已完结
皖公网安备34019202002308
